Impact of Catheter Design on Catheter Survival in Chronic Hemodialysis Patients
Primary Purpose
Chronic Hemodialysis, Catheter Related Bloodstream Infection, Mechanical Catheter Dysfunction
Status
Completed
Phase
Phase 4
Locations
Belgium
Study Type
Interventional
Intervention
Tunneled Cuffed Catheter (Palindroom, Hemoglide Bard)
Sponsored by
About this trial
This is an interventional treatment trial for Chronic Hemodialysis focused on measuring Chronic hemodialysis, Tunneled cuffed catheter, Catheter-related bloodstream infection, Mechanical catheter dysfunction, impact of catheter design on outcome
Eligibility Criteria
Inclusion Criteria:
All patients (male or female, age < 18 years) on chronic hemodialysis who require a tunneled cuffed catheter as temporary or definite vascular access are eligible. Written informed consent is required prior to inclusion.
Exclusion Criteria:
- Pregnancy or breast-feeding
- Life-expectance of < 6 months due to major co-morbid conditions
- Inability to provide informed consent
- Occlusion or inaccessibility of the right internal jugular vein
Sites / Locations
- AZ ST JAn Brugge Oostende AV
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Palindroom catheter
Hemoglide Bard Catheter
Arm Description
Insertion of Palindroom catheter
Insertion of Hemoglide Bard Catheter
Outcomes
Primary Outcome Measures
overall catheter survival rate
Secondary Outcome Measures
Mechanical catheter dysfunction: number of dialysis sessions requiring urokinase administration per 1000 catheter days; number of catheter removals for mechanical obstruction
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01649102
Brief Title
Impact of Catheter Design on Catheter Survival in Chronic Hemodialysis Patients
Official Title
Impact of Catheter Design on Catheter Survival in Chronic Hemodialysis Patients
Study Type
Interventional
2. Study Status
Record Verification Date
January 2015
Overall Recruitment Status
Completed
Study Start Date
March 2010 (undefined)
Primary Completion Date
March 2013 (Actual)
Study Completion Date
March 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
AZ Sint-Jan AV
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The trial aims to compare the performance of two tunneled cuffed catheters (TCC) in chronic hemodialysis patients. The design of the catheter may affect the propensity for thrombosis and hence intraluminal infection, as well the percentage of recirculation and hence the efficiency of dialysis.
Detailed Description
The use of tunneled cuffed catheters (TCCs) as vascular access is discouraged in the NKF DOQI guidelines, because of their propensity for infection, thrombosis, inadequate and/or irregular blood flow rates and damage to large central veins. In addition, emerging data suggest a link between catheter use and cardiovascular morbidity and mortality. Nevertheless, they are still frequently used in the hemodialysis population, either because of documented inadequate vascular access anatomy, or as a bridge to a functional permanent access.
A large number of TCC are available, that mainly differ with respect to material type, lumen diameter and design, tip design, as well as presence and design of side holes. There is currently no proven advantage of one long-term catheter design over another.
The design of the catheter tip may affect the propensity for thrombosis and hence intraluminal infection, as well the percentage of recirculation, especially when arterial and venous blood tubing are reversed. Commonly used catheters have a staggered tip design, meaning that the outflow tip extends several centimetres (typically a minimum of 2.5 cm) beyond the inflow tip, to prevent recirculation. Other designs are a split tip, or a symmetrical tip. In the latter type, used in the Palindrome® (Covidien) catheter, a spiral separator is incorporated allowing either lumen to be used as the arterial port.
Many catheters have multiple side holes, to decrease shear rate and increase flow on the arterial side and reflecting the belief that backup inflow is necessary in the case of obstruction. However, side holes can also promote thrombosis and infection due to the irregularity of their cut surfaces. Especially the distal side holes comprise a low flow zone with an increased clotting risk. The Palindrome® (Covidien) catheter has laser cut side holes, which are thought to have a smoother surface and a lower tendency to cause thrombosis.
Inadequate blood flow in a catheter is often mended by reversal of the inlet and outlet lumens. However, reversal of flow leads to a substantial increase of recirculation (from 2%-3% to 10%), affecting the efficiency of treatment. It should therefore never be used except temporarily until the problem is definitively corrected. The symmetrical tip design of the Palindrome® (Covidien) catheter allows lumen reversal without increased recirculation.
The present randomized controlled trial (RCT) is designed to evaluate in chronic hemodialysis patients the performance of two TCC with different design: the Palindrome® (Covidien), which is a symmetrical spiral z-tip catheter made from carbothane and the Hemoglide® (Bard), which has a 3 cm staggered tip and is made of polyurethane.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Hemodialysis, Catheter Related Bloodstream Infection, Mechanical Catheter Dysfunction
Keywords
Chronic hemodialysis, Tunneled cuffed catheter, Catheter-related bloodstream infection, Mechanical catheter dysfunction, impact of catheter design on outcome
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
302 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Palindroom catheter
Arm Type
Experimental
Arm Description
Insertion of Palindroom catheter
Arm Title
Hemoglide Bard Catheter
Arm Type
Experimental
Arm Description
Insertion of Hemoglide Bard Catheter
Intervention Type
Device
Intervention Name(s)
Tunneled Cuffed Catheter (Palindroom, Hemoglide Bard)
Intervention Description
A tunneled cuffed catheter is inserted, randomization between:
Palindroom
Hemoglide Bard
Primary Outcome Measure Information:
Title
overall catheter survival rate
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Mechanical catheter dysfunction: number of dialysis sessions requiring urokinase administration per 1000 catheter days; number of catheter removals for mechanical obstruction
Time Frame
3 years
Other Pre-specified Outcome Measures:
Title
Dialysis efficiency: Kt/V; mean achieved blood flow rate per dialysis session
Time Frame
3 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All patients (male or female, age < 18 years) on chronic hemodialysis who require a tunneled cuffed catheter as temporary or definite vascular access are eligible. Written informed consent is required prior to inclusion.
Exclusion Criteria:
Pregnancy or breast-feeding
Life-expectance of < 6 months due to major co-morbid conditions
Inability to provide informed consent
Occlusion or inaccessibility of the right internal jugular vein
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
An S De Vriese, M.D., Ph.D.
Organizational Affiliation
AZ ST JAN Brugge Oostende AV
Official's Role
Principal Investigator
Facility Information:
Facility Name
AZ ST JAn Brugge Oostende AV
City
Brugge
ZIP/Postal Code
B-8000
Country
Belgium
12. IPD Sharing Statement
Learn more about this trial
Impact of Catheter Design on Catheter Survival in Chronic Hemodialysis Patients
We'll reach out to this number within 24 hrs